(Q48455136)

English

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.

scientific article published on 28 June 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study. (English)

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

florbetapir (18F)

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

8

object named as

Eric M Reiman

1 reference

Europe PubMed Central

11 February 2018

3

object named as

Thomas G Beach

1 reference

Europe PubMed Central

11 February 2018

18

object named as

Mark A Mintun

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

R. Edward Coleman

5

object named as

R Edward Coleman

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

Julie A Schneider

11

object named as

Julie A Schneider

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

author name string

Christopher M Clark

1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

Michael J Pontecorvo

2

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

Barry J Bedell

4

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

P Murali Doraiswamy

6

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

Adam S Fleisher

7

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

Marwan N Sabbagh

9

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

Carl H Sadowsky

10

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

Anupa Arora

12

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

Alan P Carpenter

13

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

Matthew L Flitter

14

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

Abhinay D Joshi

15

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

Michael J Krautkramer

16

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

Ming Lu

17

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

Daniel M Skovronsky

19

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

AV-45-A16 Study Group

20

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

publication date

28 June 2012

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

Lancet Neurology

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

11

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

669-678

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

8

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970142-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970142-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970142-4

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970142-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970142-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970142-4

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970142-4

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970142-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970142-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970142-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970142-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970142-4

7 January 2021

based on heuristic

inferred from DOI database lookup

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970142-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970142-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970142-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Amyloid-beta plaque growth in cognitively normal adults: longitudinal [11C]Pittsburgh compound B data

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970142-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970142-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970142-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970142-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1474-4422(12)70142-4

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22749065

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48455136&oldid=2100775685"